5Gambaro G,Cavizana A D.Luzi P,et al.Glylosaminoglycans morphological renal alterations and albuminuria in diabetic rats[J].Kidney Int,1992,42:285-287.
9Bobek V,Kovarik J.Antitumor and anxtimetastatic effect of warfarin and heparin[J].Biomed pharmacother,2004,58:213 -219.
10Deepa P R,Varalakshmi P.Protective effects of certopar in sodium,a low molecular weight heparin derivative,inexperimental atherosclerosis[J].Clinchim Acta,2004,339:105-115.
二级参考文献26
1卫生部医政司.全国临床检验操作规程（第1版）[M].南京:东南大学出版社,1992.24.
2张天明，中国生化药物杂志，1998年，19卷，4期，194页
3卫生部医政司，全国临床检验操作规程，1992年，24页
4Carmeliet P, Jain RK. Angiogenesis in cancer and other disease. Nature, 2000,407:249-257.
5Collen A, Smorenburg SM, Peters E, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res,2000,60:6196-6200.
6El-Assal ON, Yamanoi A, Ono T, et al. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res, 2001,7:1299-1305.
7Ornstein DL, Zacharski LR. The use of heparin for treating human maliganancies. Haemostasis, 1999,29(suppl 1):48-60.
8Drixler TA, Borel Rinkes IHM, Ritchie ED, et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res, 2000,60:1761-1765.
10Merlini PA,Bauer KA,Oltrona L,et al.Persistent activation of congulation mechanism in unstable angina and myocardial infarction[J].Circulation,1994,90:61-68.
